Antitrust Compliance and Clinical Integration: Recent Developments, FTC and DOJ Scrutiny
Assessing Anti-Competitiveness of Collaborations, Minimizing Risk of Agency Challenges
A live 90-minute CLE video webinar with interactive Q&A
This CLE course will provide healthcare counsel with an examination of the latest developments concerning clinical integration programs, as well as the FTC and DOJ assessment processes. The panel will offer best practices for effective clinical integration while mitigating antitrust concerns.
Outline
- Antitrust overview
- Antitrust assessment of provider collaborations
- Is there sufficient financial or clinical integration?
- Will the network have market power--how does one go about determining product and geographic markets, or is that even necessary?
- Exclusive vs. non-exclusive networks
- How to document potential cost and quality efficiencies
- What conduct creates "red flags"?
- Addressing some common questions
- How does the network know that it is sufficiently integrated?
- When can joint negotiations begin?
- Should the network work with health plans--and if so, how?
- How relevant is evidence of cost or quality gains?
- Does working with a hospital raise or lower the antitrust risks?
- What if prices go up?
- Should the network seek an advisory opinion?
- And more
Benefits
The speakers will review these and other noteworthy issues:
- What are the lessons from the FTC's advisory opinions regarding clinical integration programs?
- What are the elements to include in a clinically integrated provider network within the meaning of antitrust law?
- What are best practices for effective clinical integration and avoiding antitrust problems?
Faculty

E. John Steren
Member
Epstein Becker & Green
Mr. Steren leverages his more than 30 years of healthcare antitrust and litigation experience to help healthcare... | Read More
Mr. Steren leverages his more than 30 years of healthcare antitrust and litigation experience to help healthcare clients manage the risks of joint ventures and other business arrangements and to defend them against government investigations and enforcement actions. He also provides counseling and litigation services to employers in connection with non-competition and pricing-related issues. Among Mr. Steren’s clients are large healthcare providers (or provider groups), such as hospitals and healthcare systems, physicians, ambulatory surgery center corporations, and other specialty care providers (e.g., chains of urological care or anesthesia providers). His clients also include large retail chains, commercial and residential lenders, and product manufacturers and distributors. A thought leader in the antitrust field, Mr. Steren speaks regularly and has authored numerous articles on antitrust issues affecting the healthcare industry.
Closeto be announced.
Early Discount (through 05/30/25)